细胞生物学
下调和上调
RNA干扰
线粒体
功能(生物学)
内皮干细胞
伤口愈合
机制(生物学)
化学
小干扰RNA
生物
内皮
癌症研究
细胞外
细胞
细胞外小泡
细胞外基质
小泡
医学
药理学
内皮功能障碍
细胞损伤
生物信息学
微泡
缝隙连接
程序性细胞死亡
糖尿病
血管生成
作者
Chengqi Yan,Hui Lu,Cheng Wang,Pengjuan Nie,Shuoyuan Liu,Kangli Qiu,Chuanan Shen,Huicai Wen,Zhenbing Chen,Xiaofan Yang
摘要
ABSTRACT Diabetic wounds remain a major clinical challenge, largely due to vascular dysfunction. Here, we identified a previously unrecognized N 6 ‐methyladenosine (m 6 A)‐dependent mechanism underlying endothelial injury in diabetic wounds. The m 6 A demethylase ALKBH5 was upregulated in diabetic wound endothelium, leading to reduced m 6 A modification within the coding sequence (CDS) of C2orf69 mRNA. Loss of m 6 A weakened IGF2BP2‐mediated stabilization of C2orf69 transcripts, resulting in decreased C2orf69 expression, mitochondrial dysfunction, and impaired angiogenesis. To therapeutically target the ALKBH5‐m 6 A‐C2orf69 axis, we developed a biomimetic membrane‐fusion nanovesicle system (siALK@L‐Hyb) integrating arginine‐rich lipopeptides (A‐LPs), endothelial cell membranes, milk‐derived extracellular vesicles (mEVs), and ALKBH5‐specific siRNA. This platform enhanced tissue penetration, promoted endothelial uptake, and facilitated lysosomal escape, thereby achieving a sequential “Tissue‐Cell‐Organelle” intervention. The resulting efficient delivery of ALKBH5 siRNA restored mitochondrial function, improved angiogenesis, and significantly accelerated diabetic wound healing. Our work not only uncovers a novel m 6 A‐regulated endothelial injury pathway in diabetic wounds, but also presents a versatile and translational nanoplatform for RNAi‐based therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI